HHS Price Negotiators: Wyden, Thompson And “Non-Interference”
Incoming Senate Finance Committee member Ron Wyden (D-Ore.) is likely to play a central role in the push for legislation to give HHS greater leverage over drug pricing under Medicare
Incoming Senate Finance Committee member Ron Wyden (D-Ore.) is likely to play a central role in the push for legislation to give HHS greater leverage over drug pricing under Medicare